Cartesian Therapeutics, Inc. · NASDAQ:RNAC
JPMorgan Chase & Co's stake in Cartesian Therapeutics, Inc. fell to 4.80% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 22, 2026
JPMorgan Chase & Co's stake in Cartesian Therapeutics, Inc. fell to 4.80%, 1,486,252 shares, as a passive investor on Jun 30, 2026. Filed Jul 22, 2026 (Schedule 13G/A).
- Stake
- 4.80%
- Shares
- 1,486,252
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 4.80% | 1,486,252 |
Source
Related
- Cartesian Therapeutics, Inc.
- JPMorgan Chase & Co
- Cartesian Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Apr 25, 2025
- Schedule 13G · Barclays PLC · Aug 13, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Form 4 · Hoge Elizabeth · Apr 6, 2026
- Form 4 · Kalayoglu Murat · Apr 6, 2026
- Schedule 13G · Squarepoint Ops LLC · Mar 13, 2026